Insilico Medicine Announces Changes to Board of Directors
HIGHLIGHTS
- •Insilico Medicine changes to its Board of Directors
- •Mr. Alex Zhavoronkov re-designated as executive director, Mr. Feng Ren appointed as co-CEO, and several others re-designated or appointed as non-executive directors.
- •These changes are significant for the company's governance and strategic direction.
Published:
Official Source (Official Website)